<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">There were several cases of long-term remission in the PIX301 study, including a case of a very durable partial response (PR) with pixantrone in a patient with relapsed diffuse large B-cell lymphoma (DLBCL) at study entry (see 
 <xref rid="Sec12" ref-type="sec">Box 1</xref>), in addition to some patients with durable CRs. In the current post-hoc analysis of data from the PIX301 trial, we explored possible correlations between patient characteristics and clinical response in these cases.
</p>
